Top 10 Life Sciences, Biotech, and Pharmaceutical Consulting Firms of 2025
Many teams across Biotech, Pharma, and MedTech tell us they rely on consulting partners to navigate pressure points in development, compliance, and commercialization. We often meet organizations that are juggling regulatory expectations, tight timelines, and internal bandwidth constraints. The right consulting support helps reduce risk, strengthen decision-making, and keep programs moving. Below is a list of leading consulting firms that shaped the industry in 2025, along […]
Supplier Qualification and Oversight Audits: Reducing Third-Party Compliance Risk
BioBoston Consulting | Strengthening Vendor Oversight Across the Supply Chain Supplier qualification and oversight audits are no longer a back-office activity. We often see regulatory findings, quality events, or supply disruptions trace back to third-party gaps that were not visible through routine documentation reviews. Effective supplier audits help organizations understand where risk truly sits across […]
Internal & Supplier Audits for Life Sciences: A Risk-Based, GxP-Aligned Framework
BioBoston Consulting | One-Stop Quality & Compliance Support for Life Sciences Internal and supplier audits often start as a compliance exercise but we frequently see them become a strategic turning point for quality maturity. Organizations come to us when recurring findings, supplier issues, or inspection pressure reveal that audits are not driving real improvement. A […]
GMP, GLP, and GCP Audits That Strengthen Quality Systems and Inspection Outcomes
BioBoston Consulting | Integrated GxP Audit Support Across the Product Lifecycle GMP, GLP, and GCP audits are often treated as separate compliance activities. In practice, we frequently see the opposite: inspection findings arise because quality systems do not operate consistently across manufacturing, laboratories, and clinical operations. Well-designed GxP audits should do more than confirm compliance. […]
From Readiness to Remediation: End-to-End Internal and Vendor Audit Support
BioBoston Consulting | Practical Audit Support Across the Product Lifecycle Audit pressure rarely starts at the audit itself. We often see organizations reach out when inspection readiness feels uncertain, internal audits uncover repeat gaps, or vendor audits raise concerns that are not easy to close. In these moments, audits shift from a scheduled activity to […]
FDA Inspection-Ready Internal Audits: Identifying Gaps Before Regulators Do
BioBoston Consulting | Proactive Internal Audit Programs for Life Sciences Internal audits are most valuable when they do more than satisfy compliance requirements, they become a proactive tool to identify gaps before regulators do. We frequently see organizations reach out after an inspection or near miss event, realizing their internal audits were not aligned with […]
Audit Programs Designed by Former FDA Investigators and Industry Experts
BioBoston Consulting | Inspection-Informed Audit Services for Life Sciences Audits are most effective when they are designed with real-world regulatory insight. We frequently see organizations conducting audits that are compliant on paper but fail to identify systemic gaps or anticipate inspection findings. At BioBoston Consulting, our audit programs are crafted by former FDA investigators and […]
Actionable Audit Findings: Practical CAPA, Root Cause, and Remediation Support
Audits are only as valuable as the improvements they drive. We often see organizations complete audits, generate reports, and then struggle to translate findings into effective corrective actions. Without proper follow-through, repeat deviations, regulatory observations, and inspection risks persist. BioBoston Consulting helps organizations turn audit findings into actionable CAPAs, root cause solutions, and measurable remediation, […]